Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$24,167,578
-$3,110,475 QoQ
Shares Held
191,290
-2.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#306
of 2,275 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ABN AMRO Bank N.V. holds $652,644,611 across 8 Drug Manufacturers - General names. GILD ranks #4 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,592,396 | $301,950,129 | |
| 2 | LLY |
ELI LILLY & Co
|
164,869 | $197,748,841 | |
| 3 | ABBV |
AbbVie Inc.
|
394,664 | $99,313,248 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
191,290 | $24,167,578 | |
| 5 | MRK |
Merck & Co., Inc.
|
136,228 | $17,505,298 | |
| 6 | JNJ |
Johnson & Johnson
|
36,256 | $9,207,936 | |
| 7 | AMGN |
Amgen Inc
|
3,988 | $1,444,134 | |
| 8 | PFE |
Pfizer Inc
|
54,296 | $1,307,447 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,167,578 | 191,290 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $27,278,053 | 195,724 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $27,351,504 | 222,841 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $5,116,101 | 46,091 | Shares | Sole | 2025-11-05 | |
| 2023-12-31 | $663,795 | 8,194 | Shares | Sole | 2025-08-28 | |
| 2023-09-30 | $614,058 | 8,194 | Shares | Sole | 2025-08-28 | |
| 2023-06-30 | $587,119 | 7,618 | Shares | Sole | 2025-08-28 | |
| No filing history on record for this holder in this stock. | ||||||